📋 Product Overview Table
| 🌐 Specification | 🧾 Details |
|---|---|
| 💊 Active Ingredient | Letrozole 2.5 mg |
| 🏭 Manufacturer | Cipla Limited |
| 💊 Dosage Form | Oral Tablet |
| 📦 Packaging | 10 Tablets in 1 Strip |
| 🩺 Indication | Hormone receptor-positive breast cancer in postmenopausal women |
| 🇺🇸 US Brand Equivalent | Femara |
| ⏱️ Delivery Time | 6 to 15 business days |
🧬 Introduction – What is Fempro 2.5mg?
Fempro 2.5mg by Cipla Limited is a generic version of Letrozole, an aromatase inhibitor primarily prescribed for postmenopausal women with hormone receptor-positive breast cancer. It works by lowering estrogen levels in the body, which helps slow or reverse the growth of hormone-sensitive tumors.
Letrozole is also commonly used as part of fertility treatment protocols due to its ability to stimulate ovulation. Fempro is a trusted, affordable Indian alternative to the global brand Femara, making it accessible for patients worldwide.
🎥 Educational Video – Letrozole Mechanism and Uses
📺 “Letrozole (Fempro) Explained: Breast Cancer & Fertility Uses“
🎬 Video Placeholder – Watch how Fempro inhibits aromatase enzyme and its key indications.
⚠️ Not suitable for premenopausal women with breast cancer unless directed by a physician.
🔬 Pharmacology & Mechanism of Action
| ⚗️ Component | 🔍 Mode of Action |
|---|---|
| Letrozole | Inhibits aromatase enzyme to block estrogen synthesis |
- Reduces estrogen levels
- Slows progression of estrogen-sensitive tumors
- Stimulates ovulation by releasing FSH in fertility treatment
💊 Dosage & Administration
| 📋 Condition | 💊 Recommended Dose |
|---|---|
| Breast cancer (postmenopausal) | 2.5 mg once daily |
| Ovulation induction (off-label use) | 2.5–5 mg daily for 5 days |
Always follow a doctor’s instructions. May be taken with or without food.
⚠️ Side Effects & Warnings
| 💥 Common Side Effects | ❗ Severe Reactions |
|---|---|
| Hot flashes, dizziness | Bone fractures, chest pain, allergic rash |
| Fatigue, nausea | Vision problems, severe abdominal pain |
| Headaches, joint pain | Liver toxicity (rare), shortness of breath |
Avoid use in patients with severe liver dysfunction or osteoporosis unless supervised.
🧃 Storage Guidelines
- Store at temperatures below 25°C (77°F)
- Protect from moisture and direct sunlight
- Keep out of reach of children
🌍 Global Buying & Import Details
| 🌎 Country | 🚚 Import Rule | 📄 Prescription Required |
|---|---|---|
| 🇺🇸 USA | FDA personal importation policy applies | ✅ Required |
| 🇬🇧 UK | Allowed via MHRA import clause | ✅ Required |
| 🇦🇺 Australia | Permitted under TGA personal import scheme | ✅ Required |
Estimated Delivery Time: 6–15 business days from India
🔗 Related Hormonal Therapy Options (Internal Links)
| 💊 Product | 🏭 Manufacturer | 📖 Short Description |
|---|---|---|
| Altraz 1mg | Alkem Laboratories Ltd | Aromatase inhibitor used for postmenopausal breast cancer |
| Armotraz | Cipla Limited | Alternative to Femara with same Letrozole content |
| Duphaston 10mg | Abbott India Pvt. Ltd. | Synthetic progesterone for hormone-related gynecological issues |
| Evadiol 2mg | Intas Pharmaceuticals | Oral estrogen tablet for menopause and HRT |
| Progynova 2mg | Zydus Healthcare | Estradiol replacement for hormonal support |
📚 Trusted References
- Drugs.com – Letrozole
- NHS Breast Cancer Guidelines
- Cipla Official Website
- PubMed – Letrozole Clinical Trials
🩺 Doctor’s Perspective – Dr. Neha Bansal, MD (Oncology)
“Fempro 2.5 mg provides an affordable, evidence-based approach to managing hormone-dependent breast cancer and is also gaining traction in assisted reproduction. It is a vital component of treatment for many women globally.”
⚠️ Disclaimer
This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before beginning treatment with Letrozole or any hormone therapy.

